CorMedix stock rating upgraded to Buy by D. Boral Capital on strong sales
PositiveFinancial Markets

CorMedix has received a significant boost as D. Boral Capital upgraded its stock rating to 'Buy' due to impressive sales figures. This upgrade is important as it reflects growing confidence in the company's performance and potential for future growth, which could attract more investors and positively impact the stock market.
— Curated by the World Pulse Now AI Editorial System